NAMA
BEAM icon

Nikko Asset Management Americas’s Beam Therapeutics BEAM Stock Holding History

Nikko Asset Management Americas’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119M Sell
3,455,043
-370,542
-10% -$11.2M 1.53% 19
2026
Q1 		$91.2M Sell
3,825,585
-583,715
-13% -$16.2M 1.29% 24
2025
Q4 		$122M Sell
4,409,300
-421,438
-9% -$10.8M 1.41% 19
2025
Q3 		$117M Buy
4,830,738
+103,939
+2% +$2.07M 1.14% 23
2025
Q2 		$80.4M Buy
4,726,799
+456,779
+11% +$7.95M 0.8% 34
2025
Q1 		$83.3M Buy
4,270,020
+312,409
+8% +$8.18M 1.07% 25
2024
Q4 		$98.1M Buy
3,957,611
+404,782
+11% +$10.3M 1.06% 28
2024
Q3 		$87M Buy
3,552,829
+1,328,414
+60% +$34.3M 0.99% 26
2024
Q2 		$52.1M Sell
2,224,415
-137,402
-6% -$3.37M 0.6% 40
2024
Q1 		$77.9M Buy
2,361,817
+3,726
+0.2% +$116K 0.77% 37
2023
Q4 		$64.1M Buy
2,358,091
+715,911
+44% +$17.8M 0.62% 40
2023
Q3 		$39.5M Buy
1,642,180
+427,100
+35% +$11.4M 0.47% 48
2023
Q2 		$38.8M Buy
1,215,080
+556,514
+85% +$18.1M 0.41% 51
2023
Q1 		$19.9M Sell
658,566
-15,124
-2% -$597K 0.23% 60
2022
Q4 		$26.3M Buy
673,690
+162,759
+32% +$7.29M 0.38% 48
2022
Q3 		$23.8M Buy
510,931
+218,969
+75% +$12.5M 0.3% 59
2022
Q2 		$10.8M Buy
291,962
+8,453
+3% +$336K 0.13% 89
2022
Q1 		$16.3M Buy
283,509
+58,286
+26% +$3.82M 0.12% 88
2021
Q4 		$18M Sell
225,223
-29,132
-11% -$2.49M 0.09% 92
2021
Q3 		$22.1M Buy
254,355
+724
+0.3% +$72.7K 0.1% 96
2021
Q2 		$33M Buy
253,631
+24,230
+11% +$1.93M 0.13% 89
2021
Q1 		$18.4M Buy
229,401
+25,159
+12% +$2.39M 0.09% 108
2020
Q4 		$16.7M Buy
+204,242
New +$10M 0.09% 110

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nikko Asset Management Americas's BEAM Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Beam Therapeutics (BEAM) stake by 9.7% in Q2 2026, selling an estimated $11.2M and leaving 3,455,043 shares worth $119M. The position accounts for 1.53% of the portfolio, ranked #19.

Nikko Asset Management Americas first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $122M in Q4 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Nikko Asset Management Americas held 3,455,043 shares of Beam Therapeutics worth $119M as of Q2 2026.
  • Nikko Asset Management Americas sold 370,542 Beam Therapeutics shares in Q2 2026, an estimated $11.2M.
  • Beam Therapeutics made up 1.53% of Nikko Asset Management Americas's portfolio in Q2 2026, its #19 holding.
  • Nikko Asset Management Americas first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Nikko Asset Management Americas's Beam Therapeutics position peaked at $122M in Q4 2025.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.